Stay updated on Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The webpage has updated its date references, removing older dates and adding new ones for March 2025. This indicates a refresh of time-sensitive content.
    Difference
    0.3%
    Check dated 2025-03-04T03:59:40.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.9%
    Check dated 2025-02-24T22:57:53.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The webpage has updated its last update dates to reflect more recent information, with the latest updates now showing as of early 2025. Additionally, there is a notice regarding heavy traffic affecting some services, which may impact performance and availability.
    Difference
    2%
    Check dated 2025-02-10T16:13:49.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T11:29:12.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T02:41:08.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-12T23:11:41.000Z thumbnail image

Stay in the know with updates to Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.